The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Patent prosecution and counseling for Rice University
Represents Rice University in pursuing patent coverage in the area of biologically active nitric oxide (NO) releasing polymers and methods of their more
Cross border commercial and M&A transactions for Neusoft Corporation
Represented Neusoft Corporation, a Chinese public company and the largest IT outsourcing service provider and software developer in China, as global more
Milliken & Company v. Interface, Inc., et al.
The firm served as lead counsel on behalf of Interface Inc., a leading manufacturer of carpet tile, in patent litigation filed by one of its largest more
Integration of Atlanta Cardiology Group P.C. into Piedmont Heart Institute, a subsidiary of the Piedmont Healthcare System
Represented Atlanta Cardiology Group P.C. with its integration from a large multi-office cardiology practice into Piedmont Heart more